Skip to main content
Fig. 10 | BMC Medicine

Fig. 10

From: Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer

Fig. 10

Macrophage subtype analysis between R-O and S-O groups and between R-O+A and R-O groups. A Macrophage subtype cluster visualization by UMAP dimension reduction analysis. B Function clusters of specific markers for M1 type macrophage annotation. C Function clusters of specific markers for M2 type macrophage annotation. D The relative abundance of various subtype macrophages was compared. E Differences in function enrichment in those cell subtypes were also noted

Back to article page